| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |